Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

[Application of alpha-fetoprotein and osteopontin combination for early diagnosis of hepatocellular carcinoma associated with hepatitis C.]

Malov SI, Malov IV, Dvornichenko VV, Rasulov RI, Kuvshinov AG, Marche PN, Decaens T, Macek-Jilkova Z, Yushchuk ND.

Klin Lab Diagn. 2019;64(10):607-612. doi: 10.18821/0869-2084-2019-64-10-607-612. Russian.

PMID:
31742954
2.

Chronic Oral Exposure to Synthetic Amorphous Silica (NM-200) Results in Renal and Liver Lesions in Mice.

Boudard D, Aureli F, Laurent B, Sturm N, Raggi A, Antier E, Lakhdar L, Marche PN, Cottier M, Cubadda F, Bencsik A.

Kidney Int Rep. 2019 Jun 22;4(10):1463-1471. doi: 10.1016/j.ekir.2019.06.007. eCollection 2019 Oct.

3.

Polarization Induced Electro-Functionalization of Pore Walls: A Contactless Technology.

Bouchet-Spinelli A, Descamps E, Liu J, Ismail A, Pham P, Chatelain F, Leïchlé T, Leroy L, Marche PN, Raillon C, Roget A, Roupioz Y, Sojic N, Buhot A, Haguet V, Livache T, Mailley P.

Biosensors (Basel). 2019 Oct 11;9(4). pii: E121. doi: 10.3390/bios9040121. Review.

4.

Immunologic Features of Patients With Advanced Hepatocellular Carcinoma Before and During Sorafenib or Anti-programmed Death-1/Programmed Death-L1 Treatment.

Macek Jilkova Z, Aspord C, Kurma K, Granon A, Sengel C, Sturm N, Marche PN, Decaens T.

Clin Transl Gastroenterol. 2019 Jul;10(7):e00058. doi: 10.14309/ctg.0000000000000058.

5.

A proliferation-inducing ligand-mediated anti-inflammatory response of astrocytes in multiple sclerosis.

Baert L, Benkhoucha M, Popa N, Ahmed MC, Manfroi B, Boutonnat J, Sturm N, Raguenez G, Tessier M, Casez O, Marignier R, Ahmadi M, Broisat A, Ghezzi C, Rivat C, Sonrier C, Hahne M, Baeten D, Vives RR, Lortat-Jacob H, Marche PN, Schneider P, Lassmann HP, Boucraut J, Lalive PH, Huard B.

Ann Neurol. 2019 Mar;85(3):406-420. doi: 10.1002/ana.25415. Epub 2019 Feb 4.

PMID:
30635946
6.

Induction of Proinflammatory Multiple Sclerosis-Associated Retrovirus Envelope Protein by Human Herpesvirus-6A and CD46 Receptor Engagement.

Charvet B, Reynaud JM, Gourru-Lesimple G, Perron H, Marche PN, Horvat B.

Front Immunol. 2018 Dec 6;9:2803. doi: 10.3389/fimmu.2018.02803. eCollection 2018.

7.

Chronic Borrelia burgdorferi infection triggers NKT lymphomagenesis.

Robinot R, Bachy E, Chaubard S, Urb M, Carras S, Bardel E, Chartoire D, Traverse-Glehen A, Marche PN, Salles G, Jaulhac B, Genestier L.

Blood. 2018 Dec 20;132(25):2691-2695. doi: 10.1182/blood-2018-07-863381. Epub 2018 Nov 2. No abstract available.

PMID:
30389696
8.

Overcoming immunogenicity issues of HIV p24 antigen by the use of innovative nanostructured lipid carriers as delivery systems: evidences in mice and non-human primates.

Bayon E, Morlieras J, Dereuddre-Bosquet N, Gonon A, Gosse L, Courant T, Le Grand R, Marche PN, Navarro FP.

NPJ Vaccines. 2018 Oct 1;3:46. doi: 10.1038/s41541-018-0086-0. eCollection 2018.

9.

Combination of AKT inhibitor ARQ 092 and sorafenib potentiates inhibition of tumor progression in cirrhotic rat model of hepatocellular carcinoma.

Jilkova ZM, Kuyucu AZ, Kurma K, Ahmad Pour ST, Roth GS, Abbadessa G, Yu Y, Schwartz B, Sturm N, Marche PN, Hainaut P, Decaens T.

Oncotarget. 2018 Jan 23;9(13):11145-11158. doi: 10.18632/oncotarget.24298. eCollection 2018 Feb 16.

10.

Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular Carcinoma.

Roth GS, Macek Jilkova Z, Zeybek Kuyucu A, Kurma K, Ahmad Pour ST, Abbadessa G, Yu Y, Busser B, Marche PN, Leroy V, Decaens T.

Mol Cancer Ther. 2017 Oct;16(10):2157-2165. doi: 10.1158/1535-7163.MCT-16-0602-T. Epub 2017 May 31.

11.

Tailoring nanostructured lipid carriers for the delivery of protein antigens: Physicochemical properties versus immunogenicity studies.

Courant T, Bayon E, Reynaud-Dougier HL, Villiers C, Menneteau M, Marche PN, Navarro FP.

Biomaterials. 2017 Aug;136:29-42. doi: 10.1016/j.biomaterials.2017.05.001. Epub 2017 May 3.

PMID:
28511142
12.

[Endogenous retroviral sequences in the human genome can play a physiological or pathological role].

Medina J, Charvet B, Leblanc P, Germi R, Horvat B, Marche PN, Perron H.

Med Sci (Paris). 2017 Apr;33(4):397-403. doi: 10.1051/medsci/20173304009. Epub 2017 May 12. Review. French.

13.

Sex Differences in Spontaneous Degranulation Activity of Intrahepatic Natural Killer Cells during Chronic Hepatitis B: Association with Estradiol Levels.

Macek Jilkova Z, Decaens T, Marlu A, Marche H, Jouvin-Marche E, Marche PN.

Mediators Inflamm. 2017;2017:3214917. doi: 10.1155/2017/3214917. Epub 2017 Apr 2.

14.

Impact of silica nanoparticle surface chemistry on protein corona formation and consequential interactions with biological cells.

Kurtz-Chalot A, Villiers C, Pourchez J, Boudard D, Martini M, Marche PN, Cottier M, Forest V.

Mater Sci Eng C Mater Biol Appl. 2017 Jun 1;75:16-24. doi: 10.1016/j.msec.2017.02.028. Epub 2017 Feb 10.

PMID:
28415450
15.

Rapid immunoassay exploiting nanoparticles and micromagnets: proof-of-concept using ovalbumin model.

Delshadi S, Blaire G, Kauffmann P, Fratzl M, Devillers T, Delabouglise D, Weidenhaupt M, Dempsey NM, Cugat O, Bruckert F, Marche PN.

Bioanalysis. 2017 Mar;9(6):517-526. doi: 10.4155/bio-2016-0232. Epub 2017 Feb 22.

PMID:
28225302
16.

CD1d-restricted peripheral T cell lymphoma in mice and humans.

Bachy E, Urb M, Chandra S, Robinot R, Bricard G, de Bernard S, Traverse-Glehen A, Gazzo S, Blond O, Khurana A, Baseggio L, Heavican T, Ffrench M, Crispatzu G, Mondière P, Schrader A, Taillardet M, Thaunat O, Martin N, Dalle S, Le Garff-Tavernier M, Salles G, Lachuer J, Hermine O, Asnafi V, Roussel M, Lamy T, Herling M, Iqbal J, Buffat L, Marche PN, Gaulard P, Kronenberg M, Defrance T, Genestier L.

J Exp Med. 2016 May 2;213(5):841-57. doi: 10.1084/jem.20150794. Epub 2016 Apr 11.

17.

Progression of fibrosis in patients with chronic viral hepatitis is associated with IL-17(+) neutrophils.

Macek Jilkova Z, Afzal S, Marche H, Decaens T, Sturm N, Jouvin-Marche E, Huard B, Marche PN.

Liver Int. 2016 Aug;36(8):1116-24. doi: 10.1111/liv.13060. Epub 2016 Feb 3.

PMID:
26749555
18.

A Simple Microfluidic Platform for Long-Term Analysis and Continuous Dual-Imaging Detection of T-Cell Secreted IFN-γ and IL-2 on Antibody-Based Biochip.

Baganizi DR, Leroy L, Laplatine L, Fairley SJ, Heidmann S, Menad S, Livache T, Marche PN, Roupioz Y.

Biosensors (Basel). 2015 Dec 4;5(4):750-67. doi: 10.3390/bios5040750.

19.

First international workshop on human endogenous retroviruses and diseases, HERVs & disease 2015.

Nath A, Küry P, Sciascia do Olival G, Dolei A, Karlsson H, Groc L, Schneider M, Kriesel J, Touraine JL, Mallet F, Marche PN, Arnaud F, Feschotte C, Perron H.

Mob DNA. 2015 Oct 15;6:20. doi: 10.1186/s13100-015-0051-7. eCollection 2015.

20.

Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.

Ramzan M, Sturm N, Decaens T, Bioulac-Sage P, Bancel B, Merle P, Tran Van Nhieu J, Slama R, Letoublon C, Zarski JP, Jouvin-Marche E, Marche PN, Leroy V.

Liver Int. 2016 Mar;36(3):434-44. doi: 10.1111/liv.12927. Epub 2015 Sep 29.

PMID:
26215124
21.

Inflammatory response of endothelial cells to a human endogenous retrovirus associated with multiple sclerosis is mediated by TLR4.

Duperray A, Barbe D, Raguenez G, Weksler BB, Romero IA, Couraud PO, Perron H, Marche PN.

Int Immunol. 2015 Nov;27(11):545-53. doi: 10.1093/intimm/dxv025. Epub 2015 May 8.

22.

Protein-peptide arrays for detection of specific anti-hepatitis D virus (HDV) genotype 1, 6, and 8 antibodies among HDV-infected patients by surface plasmon resonance imaging.

Villiers MB, Cortay JC, Cortès S, Bloquel B, Brichler S, Brakha C, Kay A, Falah N, Zoulim F, Marquette C, Marche PN, Dény P.

J Clin Microbiol. 2015 Apr;53(4):1164-71. doi: 10.1128/JCM.03002-14. Epub 2015 Jan 28.

23.

Spatial resolution in prism-based surface plasmon resonance microscopy.

Laplatine L, Leroy L, Calemczuk R, Baganizi D, Marche PN, Roupioz Y, Livache T.

Opt Express. 2014 Sep 22;22(19):22771-85. doi: 10.1364/OE.22.022771.

PMID:
25321746
24.

Photothermal effect for localized desorption of primary lymphocytes arrayed on an antibody/DNA-based biochip.

Leroy L, Bombera R, Engel E, Calemczuk R, Laplatine L, Baganizi DD, Marche PN, Roupioz Y, Livache T.

Lab Chip. 2014 Jun 21;14(12):1987-90. doi: 10.1039/c4lc00336e. Epub 2014 May 2.

PMID:
24789691
25.

Functions of liver natural killer cells are dependent on the severity of liver inflammation and fibrosis in chronic hepatitis C.

Fugier E, Marche H, Thélu MA, Macek Jílková Z, Van Campenhout N, Dufeu-Duchesne T, Leroy V, Zarski JP, Sturm N, Marche PN, Jouvin-Marche E.

PLoS One. 2014 Apr 23;9(4):e95614. doi: 10.1371/journal.pone.0095614. eCollection 2014.

26.

Developmental regulation of p53-dependent radiation-induced thymocyte apoptosis in mice.

Gentil Dit Maurin A, Lemercier C, Collin-Faure V, Marche PN, Jouvin-Marche E, Candéias SM.

Clin Exp Immunol. 2015 Jan;179(1):30-8. doi: 10.1111/cei.12329.

27.

Relationship between humoral response against hepatitis C virus and disease overcome.

Brakha C, Arvers P, Villiers F, Marlu A, Buhot A, Livache T, Calemczuk R, Zarski JP, Villiers CL, Marche PN, Villiers MB.

Springerplus. 2014 Jan 27;3:56. doi: 10.1186/2193-1801-3-56. eCollection 2014.

28.

Lymphocytes degranulation in liver in hepatitis C virus carriers is associated with IFNL4 polymorphisms and ALT levels.

Jouvin-Marche E, Macek Jílková Z, Thelu MA, Marche H, Fugier E, Van Campenhout N, Hoang XS, Marlu A, Sturm N, Callanan M, Leroy V, Zarski JP, Marche PN.

J Infect Dis. 2014 Jun 15;209(12):1907-15. doi: 10.1093/infdis/jiu016. Epub 2014 Jan 9.

PMID:
24415789
29.

Multiple sclerosis-associated retrovirus and related human endogenous retrovirus-W in patients with multiple sclerosis.

Dolei A, Garson JA, Arru G, Clerici M, Germi R, Marche PN, Perron H.

J Neuroimmunol. 2014 Jan 15;266(1-2):87-8. doi: 10.1016/j.jneuroim.2013.11.009. Epub 2013 Dec 6. No abstract available.

PMID:
24355750
30.

Human endogenous retrovirus protein activates innate immunity and promotes experimental allergic encephalomyelitis in mice.

Perron H, Dougier-Reynaud HL, Lomparski C, Popa I, Firouzi R, Bertrand JB, Marusic S, Portoukalian J, Jouvin-Marche E, Villiers CL, Touraine JL, Marche PN.

PLoS One. 2013 Dec 6;8(12):e80128. doi: 10.1371/journal.pone.0080128. eCollection 2013.

31.

Predictive toxicology of cobalt ferrite nanoparticles: comparative in-vitro study of different cellular models using methods of knowledge discovery from data.

Horev-Azaria L, Baldi G, Beno D, Bonacchi D, Golla-Schindler U, Kirkpatrick JC, Kolle S, Landsiedel R, Maimon O, Marche PN, Ponti J, Romano R, Rossi F, Sommer D, Uboldi C, Unger RE, Villiers C, Korenstein R.

Part Fibre Toxicol. 2013 Jul 29;10:32. doi: 10.1186/1743-8977-10-32.

32.

Paramagnetic nanoparticles to track and quantify in vivo immune human therapeutic cells.

Aspord C, Laurin D, Janier MF, Mandon CA, Thivolet C, Villiers C, Mowat P, Madec AM, Tillement O, Perriat P, Louis C, Bérard F, Marche PN, Plumas J, Billotey C.

Nanoscale. 2013 Dec 7;5(23):11409-15. doi: 10.1039/c3nr34240a.

PMID:
23838997
33.

A top-down synthesis route to ultrasmall multifunctional Gd-based silica nanoparticles for theranostic applications.

Mignot A, Truillet C, Lux F, Sancey L, Louis C, Denat F, Boschetti F, Bocher L, Gloter A, Stéphan O, Antoine R, Dugourd P, Luneau D, Novitchi G, Figueiredo LC, de Morais PC, Bonneviot L, Albela B, Ribot F, Van Lokeren L, Déchamps-Olivier I, Chuburu F, Lemercier G, Villiers C, Marche PN, Le Duc G, Roux S, Tillement O, Perriat P.

Chemistry. 2013 May 3;19(19):6122-36. doi: 10.1002/chem.201203003. Epub 2013 Mar 19.

PMID:
23512788
34.

Selective individual primary cell capture using locally bio-functionalized micropores.

Liu J, Bombera R, Leroy L, Roupioz Y, Baganizi DR, Marche PN, Haguet V, Mailley P, Livache T.

PLoS One. 2013;8(3):e57717. doi: 10.1371/journal.pone.0057717. Epub 2013 Mar 1.

35.

Polymer adhesive surface as flexible generic platform for multiplexed assays biochip production.

Mandon CA, Berthuy OI, Corgier BP, Le Goff GC, Faure P, Marche PN, Blum LJ, Marquette CA.

Biosens Bioelectron. 2013 Jan 15;39(1):37-43. doi: 10.1016/j.bios.2012.06.024. Epub 2012 Jun 30.

36.

Predictive toxicology of cobalt nanoparticles and ions: comparative in vitro study of different cellular models using methods of knowledge discovery from data.

Horev-Azaria L, Kirkpatrick CJ, Korenstein R, Marche PN, Maimon O, Ponti J, Romano R, Rossi F, Golla-Schindler U, Sommer D, Uboldi C, Unger RE, Villiers C.

Toxicol Sci. 2011 Aug;122(2):489-501. doi: 10.1093/toxsci/kfr124. Epub 2011 May 20.

PMID:
21602188
37.

Biosensor for direct cell detection, quantification and analysis.

Cortès S, Villiers CL, Colpo P, Couderc R, Brakha C, Rossi F, Marche PN, Villiers MB.

Biosens Bioelectron. 2011 Jun 15;26(10):4162-8. doi: 10.1016/j.bios.2011.04.016. Epub 2011 Apr 15.

PMID:
21565484
38.

Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines.

Sène D, Levasseur F, Abel M, Lambert M, Camous X, Hernandez C, Pène V, Rosenberg AR, Jouvin-Marche E, Marche PN, Cacoub P, Caillat-Zucman S.

PLoS Pathog. 2010 Nov 11;6(11):e1001184. doi: 10.1371/journal.ppat.1001184.

39.

Peptide-protein microarrays and surface plasmon resonance detection: biosensors for versatile biomolecular interaction analysis.

Villiers MB, Cortès S, Brakha C, Lavergne JP, Marquette CA, Deny P, Livache T, Marche PN.

Biosens Bioelectron. 2010 Dec 15;26(4):1554-9. doi: 10.1016/j.bios.2010.07.110. Epub 2010 Aug 4.

40.

Enhanced susceptibility of T lymphocytes to oxidative stress in the absence of the cellular prion protein.

Aude-Garcia C, Villiers C, Candéias SM, Garrel C, Bertrand C, Collin V, Marche PN, Jouvin-Marche E.

Cell Mol Life Sci. 2011 Feb;68(4):687-96. doi: 10.1007/s00018-010-0477-5. Epub 2010 Aug 18.

41.

Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesis.

Sturm N, Thélu MA, Camous X, Dimitrov G, Ramzan M, Dufeu-Duchesne T, Bonorino P, Guillermet C, Brambilla E, Arvers P, Pernollet M, Leroy V, Zarski JP, Marche PN, Jouvin-Marche E.

J Hepatol. 2010 Jul;53(1):25-35. doi: 10.1016/j.jhep.2010.02.024. Epub 2010 Apr 20.

42.

Numerical modelling of the V-J combinations of the T cell receptor TRA/TRD locus.

Thuderoz F, Simonet MA, Hansen O, Pasqual N, Dariz A, Baum TP, Hierle V, Demongeot J, Marche PN, Jouvin-Marche E.

PLoS Comput Biol. 2010 Feb 19;6(2):e1000682. doi: 10.1371/journal.pcbi.1000682.

43.

A lymphotoxin-driven pathway to hepatocellular carcinoma.

Haybaeck J, Zeller N, Wolf MJ, Weber A, Wagner U, Kurrer MO, Bremer J, Iezzi G, Graf R, Clavien PA, Thimme R, Blum H, Nedospasov SA, Zatloukal K, Ramzan M, Ciesek S, Pietschmann T, Marche PN, Karin M, Kopf M, Browning JL, Aguzzi A, Heikenwalder M.

Cancer Cell. 2009 Oct 6;16(4):295-308. doi: 10.1016/j.ccr.2009.08.021. Erratum in: Cancer Cell. 2009 Nov 6;16(5):447.

44.
45.

Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C.

Bonorino P, Ramzan M, Camous X, Dufeu-Duchesne T, Thélu MA, Sturm N, Dariz A, Guillermet C, Pernollet M, Zarski JP, Marche PN, Leroy V, Jouvin-Marche E.

J Hepatol. 2009 Sep;51(3):458-67. doi: 10.1016/j.jhep.2009.05.030. Epub 2009 Jun 25.

46.

Individual blood-cell capture and 2D organization on microarrays.

Roupioz Y, Berthet-Duroure N, Leïchlé T, Pourciel JB, Mailley P, Cortes S, Villiers MB, Marche PN, Livache T, Nicu L.

Small. 2009 Jul;5(13):1493-7. doi: 10.1002/smll.200801941. No abstract available.

PMID:
19306301
47.

From secretome analysis to immunology: chitosan induces major alterations in the activation of dendritic cells via a TLR4-dependent mechanism.

Villiers C, Chevallet M, Diemer H, Couderc R, Freitas H, Van Dorsselaer A, Marche PN, Rabilloud T.

Mol Cell Proteomics. 2009 Jun;8(6):1252-64. doi: 10.1074/mcp.M800589-MCP200. Epub 2009 Mar 11.

48.

A new role for complement C3: regulation of antigen processing through an inhibitory activity.

Villiers CL, Cretin F, Lefebvre N, Marche PN, Villiers MB.

Mol Immunol. 2008 Aug;45(13):3509-16. doi: 10.1016/j.molimm.2008.05.015. Epub 2008 Jun 27.

49.

Distinct effects of DNA-PKcs and Artemis inactivation on signal joint formation in vivo.

Touvrey C, Couedel C, Soulas P, Couderc R, Jasin M, de Villartay JP, Marche PN, Jouvin-Marche E, Candéias SM.

Mol Immunol. 2008 Jul;45(12):3383-91. doi: 10.1016/j.molimm.2008.04.004. Epub 2008 May 23.

50.

ZAP-70 restoration in mice by in vivo thymic electroporation.

Irla M, Saade M, Kissenpfennig A, Poulin LF, Leserman L, Marche PN, Jouvin-Marche E, Berger F, Nguyen C.

PLoS One. 2008 Apr 30;3(4):e2059. doi: 10.1371/journal.pone.0002059.

Supplemental Content

Loading ...
Support Center